Self-expanding stents market to reach $4.47 billion by 2030

The self-expanding stents market is projected to grow from $3.49 billion in 2025 to $3.69 billion in 2026, with demand supported by rising cardiovascular disease rates and more minimally invasive procedures. The Business Research Company says North America led the market in 2025, while Asia-Pacific is set to grow fastest through 2030.

Why it matters: - The self-expanding stents market is expanding as hospitals and physicians lean more on minimally invasive vascular treatments. - Growing cardiovascular disease prevalence is increasing demand for devices that can open blocked or narrowed vessels with less invasive procedures. - The market outlook signals opportunities for manufacturers of nitinol-based stents, drug-compatible platforms and endovascular devices.

What happened: - The Business Research Company released its Self-Expanding Stents Global Market Report 2026, covering market size, trends and a forecast through 2035. - The market is projected to rise from $3.49 billion in 2025 to $3.69 billion in 2026, a 5.8% CAGR. - The report forecasts the market will reach $4.47 billion by 2030, growing at a 4.9% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report is available here. - The full report is available here.

The details: - Self-expanding stents are flexible medical devices designed to open and keep blood vessels or other tubular structures unobstructed. - The stents are typically made from metal alloys such as nitinol. - The devices expand automatically after deployment inside the body. - They are used to treat narrowing or blockage in vessels or ducts. - The report links near-term growth to rising cardiovascular disease, more interventional cardiology procedures, better stent materials, expanded use of endovascular therapies and higher patient volumes in catheterization labs. - The longer-term forecast is supported by demand for minimally invasive treatment options, broader management of peripheral artery disease, focus on durable vascular implants, wider adoption of advanced stent technologies and higher healthcare spending on interventional devices. - Key trends include greater use of nitinol-based stents, more preference for minimally invasive vascular procedures, wider application in peripheral interventions, development of drug-compatible platforms and emphasis on long-term vessel openness. - The American Heart Association reported that the US age-adjusted death rate due to cardiovascular disease rose to 233.3 per 100,000 people in January 2024, up 4.0% from 224.4 per 100,000 in 2023.

Between the lines: - The forecast points to steady rather than explosive growth, which suggests a mature market shaped by procedural volume and device refinement. - The strongest opportunities appear tied to products that improve durability, deliver drugs or support less invasive care pathways. - Regional leadership in North America and faster growth in Asia-Pacific suggest different go-to-market strategies by geography.

What's next: - The market is expected to keep expanding through 2030 as cardiovascular disease rates and peripheral artery disease treatment needs rise. - Manufacturers may compete more on material innovation, compatibility with drug delivery and performance in minimally invasive procedures. - The report says its 2026 editions now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

The bottom line: - Self-expanding stents remain a steady-growth device market, with demand tied to rising cardiovascular burden and the shift toward less invasive vascular care.